Cargando…
Durable response of therapy-related MDS/AML with concomitant Waldenström’s macroglobulinemia treated with venetoclax and azacitidine
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9203379/ https://www.ncbi.nlm.nih.gov/pubmed/35187605 http://dx.doi.org/10.1007/s00277-022-04777-z |
_version_ | 1784728701871587328 |
---|---|
author | Hirano, Mitsuhito Tamba, Mikako Inoue, Norihito Ikegami, Michiru Onda, Naoki Shirouchi, Yuko Ishihara, Yuko Abe, Hitoshi Nishimura, Noriko Mishima, Yuko Takeuchi, Kengo Maruyama, Dai |
author_facet | Hirano, Mitsuhito Tamba, Mikako Inoue, Norihito Ikegami, Michiru Onda, Naoki Shirouchi, Yuko Ishihara, Yuko Abe, Hitoshi Nishimura, Noriko Mishima, Yuko Takeuchi, Kengo Maruyama, Dai |
author_sort | Hirano, Mitsuhito |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9203379 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-92033792022-06-18 Durable response of therapy-related MDS/AML with concomitant Waldenström’s macroglobulinemia treated with venetoclax and azacitidine Hirano, Mitsuhito Tamba, Mikako Inoue, Norihito Ikegami, Michiru Onda, Naoki Shirouchi, Yuko Ishihara, Yuko Abe, Hitoshi Nishimura, Noriko Mishima, Yuko Takeuchi, Kengo Maruyama, Dai Ann Hematol Letter to the Editor Springer Berlin Heidelberg 2022-02-21 2022 /pmc/articles/PMC9203379/ /pubmed/35187605 http://dx.doi.org/10.1007/s00277-022-04777-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Letter to the Editor Hirano, Mitsuhito Tamba, Mikako Inoue, Norihito Ikegami, Michiru Onda, Naoki Shirouchi, Yuko Ishihara, Yuko Abe, Hitoshi Nishimura, Noriko Mishima, Yuko Takeuchi, Kengo Maruyama, Dai Durable response of therapy-related MDS/AML with concomitant Waldenström’s macroglobulinemia treated with venetoclax and azacitidine |
title | Durable response of therapy-related MDS/AML with concomitant Waldenström’s macroglobulinemia treated with venetoclax and azacitidine |
title_full | Durable response of therapy-related MDS/AML with concomitant Waldenström’s macroglobulinemia treated with venetoclax and azacitidine |
title_fullStr | Durable response of therapy-related MDS/AML with concomitant Waldenström’s macroglobulinemia treated with venetoclax and azacitidine |
title_full_unstemmed | Durable response of therapy-related MDS/AML with concomitant Waldenström’s macroglobulinemia treated with venetoclax and azacitidine |
title_short | Durable response of therapy-related MDS/AML with concomitant Waldenström’s macroglobulinemia treated with venetoclax and azacitidine |
title_sort | durable response of therapy-related mds/aml with concomitant waldenström’s macroglobulinemia treated with venetoclax and azacitidine |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9203379/ https://www.ncbi.nlm.nih.gov/pubmed/35187605 http://dx.doi.org/10.1007/s00277-022-04777-z |
work_keys_str_mv | AT hiranomitsuhito durableresponseoftherapyrelatedmdsamlwithconcomitantwaldenstromsmacroglobulinemiatreatedwithvenetoclaxandazacitidine AT tambamikako durableresponseoftherapyrelatedmdsamlwithconcomitantwaldenstromsmacroglobulinemiatreatedwithvenetoclaxandazacitidine AT inouenorihito durableresponseoftherapyrelatedmdsamlwithconcomitantwaldenstromsmacroglobulinemiatreatedwithvenetoclaxandazacitidine AT ikegamimichiru durableresponseoftherapyrelatedmdsamlwithconcomitantwaldenstromsmacroglobulinemiatreatedwithvenetoclaxandazacitidine AT ondanaoki durableresponseoftherapyrelatedmdsamlwithconcomitantwaldenstromsmacroglobulinemiatreatedwithvenetoclaxandazacitidine AT shirouchiyuko durableresponseoftherapyrelatedmdsamlwithconcomitantwaldenstromsmacroglobulinemiatreatedwithvenetoclaxandazacitidine AT ishiharayuko durableresponseoftherapyrelatedmdsamlwithconcomitantwaldenstromsmacroglobulinemiatreatedwithvenetoclaxandazacitidine AT abehitoshi durableresponseoftherapyrelatedmdsamlwithconcomitantwaldenstromsmacroglobulinemiatreatedwithvenetoclaxandazacitidine AT nishimuranoriko durableresponseoftherapyrelatedmdsamlwithconcomitantwaldenstromsmacroglobulinemiatreatedwithvenetoclaxandazacitidine AT mishimayuko durableresponseoftherapyrelatedmdsamlwithconcomitantwaldenstromsmacroglobulinemiatreatedwithvenetoclaxandazacitidine AT takeuchikengo durableresponseoftherapyrelatedmdsamlwithconcomitantwaldenstromsmacroglobulinemiatreatedwithvenetoclaxandazacitidine AT maruyamadai durableresponseoftherapyrelatedmdsamlwithconcomitantwaldenstromsmacroglobulinemiatreatedwithvenetoclaxandazacitidine |